|
SHARDA CROPCHEM LIMITED (SHARDACROP.NS) Avaliação DCF
IN | Basic Materials | Agricultural Inputs | NSE
|
- ✓ Totalmente Editável: Adapte-Se Às Suas Necessidades No Excel Ou Planilhas
- ✓ Design Profissional: Modelos Confiáveis E Padrão Da Indústria
- ✓ Pré-Construídos Para Uso Rápido E Eficiente
- ✓ Não É Necessária Experiência; Fácil De Seguir
Sharda Cropchem Limited (SHARDACROP.NS) Bundle
Aprimore suas opções de investimento com a calculadora DCF Sharda Cropchem Limited (Shardacropns)! Explore dados financeiros reais, ajuste as projeções e despesas de crescimento e observe como essas modificações afetam o valor intrínseco da Sharda Cropchem Limited (Shardacropns) em tempo real.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 19,981.6 | 23,912.3 | 35,757.0 | 40,451.6 | 31,607.5 | 36,385.9 | 41,886.6 | 48,219.0 | 55,508.7 | 63,900.4 |
| Revenue Growth, % | 0 | 19.67 | 49.53 | 13.13 | -21.86 | 15.12 | 15.12 | 15.12 | 15.12 | 15.12 |
| EBITDA | 3,379.4 | 4,959.4 | 7,245.8 | 6,990.3 | 3,426.2 | 6,261.1 | 7,207.6 | 8,297.2 | 9,551.6 | 10,995.6 |
| EBITDA, % | 16.91 | 20.74 | 20.26 | 17.28 | 10.84 | 17.21 | 17.21 | 17.21 | 17.21 | 17.21 |
| Depreciation | 1,371.2 | 1,704.4 | 2,453.3 | 2,481.2 | 2,671.3 | 2,578.8 | 2,968.6 | 3,417.4 | 3,934.1 | 4,528.8 |
| Depreciation, % | 6.86 | 7.13 | 6.86 | 6.13 | 8.45 | 7.09 | 7.09 | 7.09 | 7.09 | 7.09 |
| EBIT | 2,008.1 | 3,255.0 | 4,792.4 | 4,509.1 | 754.9 | 3,682.3 | 4,239.0 | 4,879.8 | 5,617.5 | 6,466.8 |
| EBIT, % | 10.05 | 13.61 | 13.4 | 11.15 | 2.39 | 10.12 | 10.12 | 10.12 | 10.12 | 10.12 |
| Total Cash | 1,953.5 | 1,706.0 | 3,003.6 | 2,424.4 | 3,603.9 | 3,107.8 | 3,577.7 | 4,118.5 | 4,741.1 | 5,457.9 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 9,889.2 | 11,625.6 | 15,399.6 | 18,333.1 | 14,980.0 | 17,020.7 | 19,593.9 | 22,556.0 | 25,966.0 | 29,891.5 |
| Account Receivables, % | 49.49 | 48.62 | 43.07 | 45.32 | 47.39 | 46.78 | 46.78 | 46.78 | 46.78 | 46.78 |
| Inventories | 3,822.4 | 5,255.5 | 8,927.8 | 11,343.4 | 9,916.4 | 9,132.2 | 10,512.8 | 12,102.1 | 13,931.7 | 16,037.9 |
| Inventories, % | 19.13 | 21.98 | 24.97 | 28.04 | 31.37 | 25.1 | 25.1 | 25.1 | 25.1 | 25.1 |
| Accounts Payable | 6,865.9 | 8,067.5 | 11,775.6 | 13,775.7 | 9,211.5 | 11,951.3 | 13,758.1 | 15,838.0 | 18,232.4 | 20,988.7 |
| Accounts Payable, % | 34.36 | 33.74 | 32.93 | 34.05 | 29.14 | 32.85 | 32.85 | 32.85 | 32.85 | 32.85 |
| Capital Expenditure | -1,759.9 | -2,312.0 | -2,337.9 | -2,440.8 | -2,720.9 | -2,885.9 | -3,322.2 | -3,824.4 | -4,402.6 | -5,068.2 |
| Capital Expenditure, % | -8.81 | -9.67 | -6.54 | -6.03 | -8.61 | -7.93 | -7.93 | -7.93 | -7.93 | -7.93 |
| Tax Rate, % | 55.64 | 55.64 | 55.64 | 55.64 | 55.64 | 55.64 | 55.64 | 55.64 | 55.64 | 55.64 |
| EBITAT | 1,788.6 | 2,410.6 | 3,605.4 | 3,579.7 | 334.9 | 2,666.8 | 3,069.9 | 3,534.0 | 4,068.3 | 4,683.3 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -5,445.7 | -164.9 | -17.3 | 271.1 | 501.1 | 3,842.9 | 569.4 | 655.5 | 754.5 | 868.6 |
| WACC, % | 10.06 | 9.99 | 9.99 | 10.01 | 9.84 | 9.98 | 9.98 | 9.98 | 9.98 | 9.98 |
| PV UFCF | ||||||||||
| SUM PV UFCF | 5,513.2 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | 886 | |||||||||
| Terminal Value | 11,102 | |||||||||
| Present Terminal Value | 6,900 | |||||||||
| Enterprise Value | 12,413 | |||||||||
| Net Debt | -690 | |||||||||
| Equity Value | 13,103 | |||||||||
| Diluted Shares Outstanding, MM | 90 | |||||||||
| Equity Value Per Share | 145.24 |
What You Will Receive
- Authentic SHARDACROPNS Financial Data: Pre-loaded with Sharda Cropchem's historical and forecasted financial figures for accurate analysis.
- Completely Customizable Template: Easily adjust key inputs such as revenue growth, WACC, and EBITDA percentage.
- Instant Calculations: View the updated intrinsic value of Sharda Cropchem immediately as you modify inputs.
- Professional Valuation Tool: Tailored for investors, analysts, and consultants in search of reliable DCF results.
- User-Friendly Layout: Straightforward organization and clear guidance suitable for all levels of expertise.
Key Features
- Customizable Forecast Inputs: Adjust essential parameters such as revenue growth, EBITDA %, and capital expenditures tailored for Sharda Cropchem Limited (SHARDACROPNS).
- Instant DCF Valuation: Automatically calculates intrinsic value, NPV, and other vital metrics for informed decision-making.
- Exceptional Accuracy: Leverages Sharda Cropchem Limited's (SHARDACROPNS) actual financial data to deliver realistic valuation insights.
- Simplified Scenario Analysis: Effortlessly explore various assumptions and analyze different outcomes.
- Efficient Modeling Tool: Save time by avoiding the complexities of building valuation models from the ground up.
How It Functions
- 1. Access the Template: Download and open the Excel file containing Sharda Cropchem Limited’s (SHARDACROPNS) preloaded data.
- 2. Adjust Assumptions: Modify critical inputs such as growth rates, WACC, and capital expenditures.
- 3. View Results in Real-Time: The DCF model automatically computes intrinsic value and NPV.
- 4. Explore Scenarios: Analyze various forecasts to evaluate different valuation results.
- 5. Present with Assurance: Deliver professional valuation insights to reinforce your decision-making process.
Why Select This Calculator for Sharda Cropchem Limited?
- All-in-One Solution: Features DCF, WACC, and comprehensive financial ratio analyses in a single platform.
- Flexible Inputs: Modify the yellow-highlighted fields to explore different financial scenarios.
- In-Depth Analysis: Automatically computes the intrinsic value and Net Present Value for Sharda Cropchem Limited (SHARDACROPNS).
- Preloaded Information: Includes historical and projected data for a reliable foundation.
- High-Quality Standards: Tailored for financial analysts, investors, and business consultants working with Sharda Cropchem Limited.
Who Can Benefit from This Product?
- Investors: Evaluate Sharda Cropchem Limited’s (SHARDACROPNS) valuation prior to making stock transactions.
- CFOs and Financial Analysts: Optimize valuation methodologies and assess financial forecasts.
- Startup Founders: Understand the valuation models of leading public companies like Sharda Cropchem Limited.
- Consultants: Provide comprehensive valuation reports to your clients.
- Students and Educators: Utilize real-world data to enhance learning and apply valuation strategies.
Contents of the Template
- Pre-Filled DCF Model: Sharda Cropchem Limited's financial information preloaded for immediate application.
- WACC Calculator: Comprehensive calculations for Weighted Average Cost of Capital.
- Financial Ratios: Assess Sharda Cropchem's profitability, leverage, and operational efficiency.
- Editable Inputs: Customize variables such as growth rates, profit margins, and capital expenditures to suit your analytical needs.
- Financial Statements: Annual and quarterly reports provided for in-depth analysis.
- Interactive Dashboard: Conveniently visualize essential valuation metrics and outcomes.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.